Utama › Penyakit Paru Interstisial › Alabama › Birmingham
Kajian klinikal Penyakit Paru Interstisial di Birmingham, AL
9 kajian untuk Penyakit Paru Interstisial sedang mencari peserta di lokasi dalam dan sekitar Birmingham (dalam lingkungan kira-kira 30 batu). Buka kajian untuk melihat siapa yang layak menyertai dan cara menghubungi pasukan kajian.
Teks kajian rasmi (Bahasa Inggeris)
Mengambil peserta untuk kajian di sini? Paparkan di bahagian atas halaman ini — $99 selama 30 hari →
FIBRONEER-ACT: A Study to Test Whether Nerandomilast Helps People With Fibrosing Interstitial Lung Disease at Risk for Disease Progression
Mengambil pesertaFasa 3
- University of Alabama at Birmingham, Birmingham
LAM-001 for the Treatment of Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)
Mengambil pesertaFasa 2
- University of Alabama, Birmingham
A Phase 2 Study of LTI-03 in Patients With Idiopathic Pulmonary Fibrosis
Mengambil pesertaFasa 2
- UAB Lung Health Center, Birmingham
Multi-site Study of the Clinical Impact of an AI-assisted Approach to Referring Patients With Interstitial Lung Disease for Diagnostic Evaluation of Pulmonary Hypertension
Mengambil peserta
- University of Alabama at Birmingham, Birmingham
DeciPHer-ILD: A Real-world Patient Registry in Group 3 Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)
Mengambil pesertaKajian pemerhatian
- University of Alabama at Birmingham, Birmingham
Platform Clinical Study for Conquering Scleroderma
Mengambil pesertaFasa 2
- University of Alabama - Division of Pulmonary and Critical Care Medicine, Birmingham
Idiopathic Pulmonary Fibrosis and Interstitial Lung Disease Prospective Outcomes Registry
Mengambil pesertaKajian pemerhatian
- University of Alabama - Birmingham, Birmingham
Study of the Efficacy and Safety of Inhaled Treprostinil in Subjects With Progressive Pulmonary Fibrosis (TETON-PPF)
Mengambil pesertaFasa 3
- UAB Lung Health Center, Birmingham
Study Evaluating INS018_055 Administered Orally to Subjects With Idiopathic Pulmonary Fibrosis
Mengambil pesertaFasa 2
- University of Alabama at Birmingham, Birmingham
Kajian Penyakit Paru Interstisial di bandar lain
- New York City, NY18 kajian
- Philadelphia, PA16 kajian
- Los Angeles, CA14 kajian
- Kansas City, KS13 kajian
- Durham, NC13 kajian
- Charleston, SC13 kajian
- Chicago, IL12 kajian
- Houston, TX12 kajian
- Ann Arbor, MI11 kajian
- Aurora, CO11 kajian
- Phoenix, AZ9 kajian
- Salt Lake City, UT9 kajian
Kajian lain di Birmingham
- Kanser (semua jenis)30 kajian
- Kanser Payudara24 kajian
- Obesiti23 kajian
- Kanser Ovari23 kajian
- Kanser Paru-paru Bukan Sel Kecil22 kajian
- Leukemia Mieloid Akut21 kajian
- Mieloma Pelbagai18 kajian
- COPD17 kajian
- Penyakit Kardiovaskular17 kajian
- Berat Badan Berlebihan16 kajian
- Kanser Endometrium16 kajian
- Diabetes Jenis 216 kajian
Daripada ClinicalTrials.gov, data diperoleh pada 5 Okt 2026. Setiap kajian menetapkan kriteria kelayakannya sendiri; pasukan kajian menentukan siapa yang layak menyertai.